Given the substantial amount of time and money that it takes to bring a new drug to market – an average of 10 years and US $2.6 billion – it is imperative that drug discovery teams utilise the smartest technologies available. Iconic specialises in advanced language technologies (the field of Natural Language Processing), and leverages these core strengths to assist in many phases of the drug development process.
Translation is frequently required in the course of bringing a drug to market, including in drug discovery, clinical research, regulatory submissions, manufacturing, marketing and packaging. Iconic’s bespoke Neural MT solutions are built specifically for each of our customers’ use cases. Our best-in-class, proprietary software is developed in-house by our team of expert scientists, ensuring that our machine translation is helping you to get the results you need, faster and more efficiently than ever before, all while maintaining necessary quality requirements.
It is clear that to be competitive, new technologies must be embraced. Now more than ever, it is essential to employ machine learning, NLP, and artificial intelligence technologies to assist with digital transformation and process automation initiatives. Iconic’s tailored solutions are built to create the most effective workflows.
Whether using Neural MT for conducting multilingual patent searches, using NLP processes to extract information, or machine learning technology to automate processes, Iconic has the know-how to create a bespoke solution just for you.
The CAS case study illustrates how Iconic developed innovative machine learning approaches to extend its existing Machine Translation (MT) and Natural Language Processing (NLP) solutions for a large-scale project of digitisation, translation, extraction and indexing for CAS, a division of the American Chemical Society.